PL EN


Preferences help
enabled [disable] Abstract
Number of results
2017 | 17 | 4 | 221–226
Article title

Raz jeszcze o leczeniu bólu receptorowego – czy warto łączyć diklofenak z witaminami grupy B?

Content
Title variants
EN
Once again on the treatment of nociceptive pain – is it worth to combine diclofenac with B vitamins?
Languages of publication
PL
Abstracts
PL
Bóle kręgosłupa są częstą dolegliwością o  złożonej patofizjologii. Wytyczne dotyczące leczenia oscylują między postępowaniem fizjoterapeutycznym, farmakoterapią a leczeniem operacyjnym. Wydaje się, że każdy pacjent wymaga indywidualnego podejścia, co jest szczególnie ważne w  przypadku chorych w  starszym wieku  – ze względu na wielochorobowość i politerapię. Artykuł przedstawia korzyści i ograniczenia terapii diklofenakiem i witaminami grupy B w  leczeniu bólu, głównie o  charakterze kostno-stawowym. Diklofenak należy do grupy niesteroidowych leków przeciwbólowych i przeciwzapalnych. Cechuje się wysoką skutecznością terapeutyczną w zakresie bólu receptorowego, ale wywołuje także istotne działania niepożądane, w tym nadciśnienie tętnicze. Działanie przeciwbólowe witamin grupy B nie jest do końca wyjaśnione; wydaje się, że mogą one wpływać na zwiększenie ośrodkowej sekrecji serotoniny, regulować przewodnictwo dośrodkowe w zakresie rdzenia kręgowego lub – jak wskazują niektórzy, bardziej optymistyczni autorzy – wzmagać uwalnianie endogennych opioidów. W artykule zawarte są informacje na temat łączenia obu leków w kontekście skuteczności i bezpieczeństwa leczenia bólu receptorowego.
EN
Spine pain is a  frequent ailment with a  complex pathophysiology. The guidelines for treatment oscillate between physiotherapeutic procedure, pharmacotherapy and surgical treatment. It seems that every patient requires an individual approach which is especially important in case of elderly patients – due to multiple morbidities and polytherapy. The article presents the benefits and the limitations of the therapy applying diclofenac and B vitamins in the treatment of pain, mainly osteo-articular pain. Diclofenac belongs to the group of non-steroidal analgesic and anti-inflammatory drugs. It demonstrates high therapeutic efficacy in the scope of nociceptive pain, however, it also causes significant adverse effects including arterial hypertension. The analgesic effect of group B vitamins has not been fully explained; it seems that they may affect the increase of the secretion of serotonin in the central nervous system, regulate afferent conduction in the scope of the spinal cord or – as indicated by some, more optimistic, authors – enhance the release of endogenous opioids. The article includes information referring to combining both drugs in the context of the efficacy and safety of treating nociceptive pain.
Discipline
Year
Volume
17
Issue
4
Pages
221–226
Physical description
Contributors
  • Zakład Farmakokinetyki iTerapii Monitorowanej, Katedra Farmakologii, Pomorski Uniwersytet Medyczny w Szczecinie, Szczecin, Polska
References
  • Abdulmajeed NA, Alnahdi HS, Ayas NO et al.: Amelioration of cardiotoxic impacts of diclofenac sodium by vitamin B complex. Eur Rev Med Pharmacol Sci 2015; 19: 671–681.
  • American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons: Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009; 57: 1331–1346.
  • Arts NJ, Walvoort SJ, Kessels RP: Korsakoff ’s syndrome: a critical review. Neuropsychiatr Dis Treat 2017; 13: 2875–2890.
  • Bally M, Dendukuri N, Rich B et al.: Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ 2017; 357: j1909.
  • Chang HY, Tang FY, Chen DY et al.: Clinical use of cyclooxygenase inhibitors impairs vitamin B-6 metabolism. Am J Clin Nutr 2013; 98: 1440–1449.
  • Chiu CK, Low TH, Tey YS et al.: The efficacy and safety of intramuscular injections of methylcobalamin in patients with chronic nonspecific low back pain: a randomised controlled trial. Singapore Med J 2011; 52: 868–873.
  • Chou R, Deyo R, Friedly J et al.: Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians Clinical Practice guideline. Ann Intern Med 2017; 166: 480–492.
  • Collie JTB, Greaves RF, Jones OAH et al.: Vitamin B1 in critically ill patients: needs and challenges. Clin Chem Lab Med 2017; 55: 1652–1668.
  • Dardiotis E, Arseniou S, Sokratous M et al.: Vitamin B12, folate, and homocysteine levels and multiple sclerosis: a meta-analysis. Mult Scler Relat Disord 2017; 17: 190–197.
  • Enthoven WT, Roelofs PD, Deyo RA et al.: Non-steroidal anti-inflammatory drugs for chronic low back pain. Cochrane Database Syst Rev 2016; 2: CD012087.
  • Garza AF, Monroy-Maya R, Soto-Ríos M et al.: A pilot study of the effect of diclofenac with B vitamins for the treatment of acute pain following lower-limb fracture and surgery. Proc West Pharmacol Soc 2008; 51: 70–72.
  • Geller M, Mibielli MA, Nunes CP et al.: Comparison of the action of diclofenac alone versus diclofenac plus B vitamins on mobility in patients with low back pain. J Drug Assess 2016; 5: 1–3.
  • Gujjarlamudi HB: Polytherapy and drug interactions in elderly. J Midlife Health 2016; 7: 105–107.
  • Hedaya R: Five herbs plus thiamine reduce pain and improve functional mobility in patients with pain: a pilot study. Altern Ther Health Med 2017; 23: 14–19.
  • Ijaz S, Thorley H, Porter K et al.: Interventions for preventing or treating malnutrition in homeless problem-drinkers: a systematic review. Int J Equity Health 2018; 17: 8.
  • Jarosz M: Normy żywienia dla populacji polskiej – nowelizacja. Instytut Żywności i Żywienia, Warszawa 2012.
  • Kuhlwein A, Meyer HJ, Koehler CO: [Reduced diclofenac administration by B vitamins: results of a randomized double-blind study with reduced daily doses of diclofenac (75 mg diclofenac versus 75 mg diclofenac plus B vitamins) in acute lumbar vertebral syndromes]. Klin Wochenschr 1990; 68:107–115.
  • Li G: [Effect of mecobalamin on diabetic neuropathies. Beijing Methycobal Clinical Trial Collaborative Group]. Zhonghua Nei Ke Za Zhi 1999; 38: 14–17.
  • Magaña-Villa MC, Rocha-González HI, Fernández del ValleLaisequilla C et al.: B-vitamin mixture improves the analgesic effect of diclofenac in patients with osteoarthritis: a double blind study. Drug Res (Stuttg) 2013; 63: 289–292.
  • Martí-Carvajal AJ, Solà I, Lathyris D et al.: Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2017; 8: CD006612.
  • Mibielli MA, Geller M, Cohen JC et al.: Diclofenac plus B vitamins versus diclofenac monotherapy in lumbago: the DOLOR study. Curr Med Res Opin 2009; 25: 2589–2599.
  • Mutschler E, Geisslinger G, Kroemer HK et al. (eds.): Kompendium farmakologii i toksykologii Mutschlera. MedPharm Polska, Wrocław 2007.
  • National Institute for Health and Care Excellence: Low back pain and sciatica in over 16s: assessment and management. NICE guideline [NG59], November 2016. Available from: https://www.nice.org.uk/ guidance/ng59. Ozen S,
  • Ozer MA, Akdemir MO: Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain. Graefes Arch Clin Exp Ophthalmol 2017; 255: 1173–1177.
  • Pérez-Flores E, Medina-Santillán R, Reyes-García G et al.: Combination of diclofenac plus B vitamins in acute pain after tonsillectomy: a pilot study. Proc West Pharmacol Soc 2003; 46: 88–90.
  • Ponce-Monter HA, Ortiz MI, Garza-Hernández AF et al.: Effect of diclofenac with B vitamins on the treatment of acute pain originated by lower-limb fracture and surgery. Pain Res Treat 2012; 2012: 104782.
  • Qaseem A, Wilt TJ, McLean RM et al.: Noninvasive treatments for acute, subacute, and chronic low back pain: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2017; 166: 514–530.
  • Robinson K, Arheart K, Refsum H et al.: Low circulating folate and vitamin B6 concentrations: risk factors for stroke, peripheral vascular disease, and coronary artery disease. European COMAC Group. Circulation 1998; 97: 437–443.
  • Waikakul W, Waikakul S: Methylcobalamin as an adjuvant medication in conservative treatment of lumbar spinal stenosis. J Med Assoc Thai 2000; 83: 825–831.
  • Wu XY, Lu L: Vitamin B6 deficiency, genome instability and cancer. Asian Pac J Cancer Prev 2012; 13: 5333–5338.
  • Zhang M, Han W, Hu S et al.: Methylcobalamin: a potential vitamin of pain killer. Neural Plast 2013; 2013: 424651.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-d526d116-d489-462b-9e79-7500314daa04
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.